MNKD - MannKind Corporation
NASDAQ
->
Healthcare
->
Biotechnology
Westlake Village,
United States
Type: Equity
MNKD price evolution
MNKD
| (in millions $) | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $238.48 | $83.02 | $86.18 | $85.87 |
| Short term investments | $56.62 | $58 | $58.16 | $80.27 |
| Net receivables | $14.9 | $21.82 | $27.79 | $19.71 |
| Inventory | $28.55 | $27.12 | $25.29 | $22 |
| Total current assets | $373.39 | $225.57 | $230.23 | $223.3 |
| Long term investments | $7.16 | $3.27 | $2.28 | $0.49 |
| Property, plant & equipment | $84.22 | $80.41 | $69.51 | $54.84 |
| Goodwill & intangible assets | $3 | $3.02 | $3.04 | $3.13 |
| Total noncurrent assets | $101.81 | $94.75 | $83.19 | $74.84 |
| Total investments | $63.77 | $61.27 | $60.45 | $80.77 |
| Total assets | $475.2 | $320.33 | $313.42 | $298.14 |
| Current liabilities | ||||
| Accounts payable | $9.58 | $16.75 | $17.13 | $13.89 |
| Deferred revenue | $78.88 | $73.14 | $63.74 | $47.98 |
| Short long term debt | $29.81 | $29.75 | $26.35 | $21.29 |
| Total current liabilities | $104.13 | $96.37 | $96.97 | $81.85 |
| Long term debt | $483 | $351.9 | $356.81 | $361.61 |
| Total noncurrent liabilities | $617.24 | $475.73 | $476.94 | $471.68 |
| Total debt | $512.81 | $381.65 | $383.16 | $382.91 |
| Total liabilities | $721.37 | $572.11 | $573.91 | $553.53 |
| Shareholders' equity | ||||
| Retained earnings | -$3229.41 | -$3230.81 | -$3232.53 | -$3227.26 |
| Other shareholder equity | $0.44 | $0.44 | ||
| Total shareholder equity | -$246.17 | -$251.78 | -$260.49 | -$255.4 |
| (in millions $) | 31 Dec 2023 | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $238.48 | $69.77 | $124.18 | $67.16 |
| Short term investments | $56.62 | $101.08 | $79.93 | |
| Net receivables | $14.9 | $16.8 | $4.99 | $4.22 |
| Inventory | $28.55 | $21.77 | $7.15 | $4.97 |
| Total current assets | $373.39 | $234.9 | $219.74 | $79.48 |
| Long term investments | $7.16 | $1.96 | $56.62 | |
| Property, plant & equipment | $84.22 | $45.13 | $36.61 | $25.87 |
| Goodwill & intangible assets | $3 | $3.58 | ||
| Total noncurrent assets | $101.81 | $60.39 | $101.42 | $29.13 |
| Total investments | $63.77 | $103.04 | $136.55 | |
| Total assets | $475.2 | $295.28 | $321.16 | $108.61 |
| Current liabilities | ||||
| Accounts payable | $9.58 | $11.05 | $6.96 | $5.58 |
| Deferred revenue | $78.88 | $39.42 | $20.37 | $34.94 |
| Short long term debt | $29.81 | $9.56 | $6.98 | $4.06 |
| Total current liabilities | $104.13 | $67.3 | $48.35 | $73.7 |
| Long term debt | $483 | $368 | $375.77 | $119.38 |
| Total noncurrent liabilities | $617.24 | $478.52 | $482.16 | $215.32 |
| Total debt | $512.81 | $382.91 | $382.74 | $123.44 |
| Total liabilities | $721.37 | $545.82 | $530.51 | $289.03 |
| Shareholders' equity | ||||
| Retained earnings | -$3229.41 | -$3217.47 | -$3130.07 | -$3049.14 |
| Other shareholder equity | ||||
| Total shareholder equity | -$246.17 | -$250.54 | -$209.35 | -$180.42 |
| (in millions $) | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $58.47 | $51.25 | $48.61 | $40.63 |
| Cost of revenue | $18.07 | $14.25 | $14.24 | $16.21 |
| Gross Profit | $40.41 | $37 | $34.37 | $24.41 |
| Operating activities | ||||
| Research & development | $9.24 | $9.99 | $6.45 | $5.61 |
| Selling, general & administrative | $20.54 | $23.98 | $25.95 | $23.85 |
| Total operating expenses | $29.77 | $33.97 | $32.4 | $29.46 |
| Operating income | $10.63 | $3.03 | $1.97 | -$5.04 |
| Income from continuing operations | ||||
| EBIT | $8.32 | $7 | $4.06 | -$4.58 |
| Income tax expense | $1.56 | |||
| Interest expense | $5.36 | $5.27 | $9.32 | $5.21 |
| Net income | ||||
| Net income | $1.4 | $1.72 | -$5.26 | -$9.79 |
| Income (for common shares) | $1.4 | $1.72 | -$5.26 | -$9.79 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $198.96 | $99.77 | $75.44 | $65.14 |
| Cost of revenue | $62.77 | $57.5 | $38.86 | $24.64 |
| Gross Profit | $136.19 | $42.27 | $36.59 | $40.5 |
| Operating activities | ||||
| Research & development | $31.28 | $19.72 | $12.31 | $6.25 |
| Selling, general & administrative | $94.31 | $91.47 | $77.42 | $59.04 |
| Total operating expenses | $125.6 | $111.19 | $90.17 | $80.41 |
| Operating income | $10.59 | -$68.92 | -$53.59 | -$39.91 |
| Income from continuing operations | ||||
| EBIT | $14.78 | -$62.63 | -$64.35 | -$47.99 |
| Income tax expense | $1.56 | -$0.22 | ||
| Interest expense | $25.16 | $24.77 | $16.58 | $9.47 |
| Net income | ||||
| Net income | -$11.94 | -$87.4 | -$80.93 | -$57.24 |
| Income (for common shares) | -$11.94 | -$87.4 | -$80.93 | -$57.24 |
| (in millions $) | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Net income | $1.4 | $1.72 | -$5.26 | -$9.79 |
| Operating activities | ||||
| Depreciation | $1.55 | $1.46 | $1.43 | $1.4 |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $3.81 | $4.6 | $5.58 | $3.65 |
| Total cash flows from operations | $21.68 | $8.66 | $2.6 | $1.16 |
| Investing activities | ||||
| Capital expenditures | -$5.87 | -$11.39 | -$16.87 | -$8.31 |
| Investments | -$2.02 | -$0.54 | $20.53 | $22.1 |
| Total cash flows from investing | -$7.89 | -$11.55 | $3.66 | $13.79 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $0.74 | $4.04 | $2.59 | $1.23 |
| Net borrowings | $140.9 | -$1.69 | -$0.04 | -$0.07 |
| Total cash flows from financing | $141.68 | -$0.28 | -$5.95 | $1.15 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | $155.46 | -$3.17 | $0.32 | $16.1 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | -$11.94 | -$87.4 | -$80.93 | -$57.24 |
| Operating activities | ||||
| Depreciation | $5.84 | $9.11 | $5.47 | $3.33 |
| Business acquisitions & disposals | -$15.34 | -$3.98 | ||
| Stock-based compensation | $17.65 | $13.45 | $12.2 | $6.51 |
| Total cash flows from operations | $34.09 | -$80.68 | -$61.71 | -$28.13 |
| Investing activities | ||||
| Capital expenditures | -$42.44 | -$7.59 | -$11.47 | -$0.8 |
| Investments | $40.07 | $27.8 | -$140.07 | $20 |
| Total cash flows from investing | -$1.99 | $4.87 | -$151.54 | $15.22 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $8.6 | $22.49 | $1.95 | $34.75 |
| Net borrowings | $139.09 | -$0.02 | $278.93 | $14.87 |
| Total cash flows from financing | $136.61 | $21.39 | $270.27 | $49.85 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | $168.71 | -$54.42 | $57.02 | $36.94 |
News
Fundamentals
| Market cap | $1.10B |
|---|---|
| Enterprise value | $1.38B |
| Shares outstanding | 270.03M |
| Revenue | $198.96M |
|---|---|
| EBITDA | $20.62M |
| EBIT | $14.78M |
| Net Income | -$11.94M |
| Revenue Q/Q | 62.16% |
| Revenue Y/Y | 99.42% |
| P/E ratio | -92.29 |
|---|---|
| EV/Sales | 6.92 |
| EV/EBITDA | 66.73 |
| EV/EBIT | 93.08 |
| P/S ratio | 5.54 |
| P/B ratio | -4.48 |
| Book/Share | -0.91 |
| Cash/Share | 0.88 |
| EPS | -$0.04 |
|---|---|
| ROA | -3.39% |
| ROE | 4.71% |
| Debt/Equity | -2.93 |
|---|---|
| Net debt/EBITDA | 23.42 |
| Current ratio | 3.59 |
| Quick ratio | 3.31 |